Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,317 | 309 | 96.5% |
| Education | $191.69 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $676.62 | 51 | $0 (2024) |
| Lilly USA, LLC | $635.29 | 46 | $0 (2024) |
| GlaxoSmithKline, LLC. | $568.61 | 34 | $0 (2024) |
| ABBVIE INC. | $456.24 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $448.24 | 23 | $0 (2024) |
| Astellas Pharma US Inc | $442.95 | 17 | $0 (2024) |
| PFIZER INC. | $278.36 | 16 | $0 (2024) |
| Daiichi Sankyo Inc. | $188.39 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $157.38 | 9 | $0 (2024) |
| Silk Road Medical, Inc. | $135.27 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,398 | 75 | Novo Nordisk Inc ($185.57) |
| 2023 | $1,822 | 95 | Lilly USA, LLC ($311.98) |
| 2022 | $1,956 | 126 | Novo Nordisk Inc ($291.00) |
| 2021 | $333.08 | 16 | Astellas Pharma US Inc ($151.70) |
All Payment Transactions
312 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Biological | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: VACCINES | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Biological | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Obesity | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: DIABETES | ||||||
| 08/20/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Diagnostics | ||||||
| 08/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 614 | 738 | $120,563 | $56,331 |
| 2022 | 12 | 427 | 530 | $90,327 | $41,056 |
| 2021 | 1 | 16 | 17 | $2,686 | $1,732 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $48,000 | $14,836 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 121 | $20,570 | $9,956 | 48.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $8,925 | $7,897 | 88.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 41 | 41 | $10,414 | $5,569 | 53.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 24 | 61 | $8,357 | $4,797 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 61 | $7,320 | $3,426 | 46.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 15 | 15 | $3,810 | $2,090 | 54.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 27 | $2,305 | $1,942 | 84.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 17 | 20 | $2,740 | $1,629 | 59.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 59 | 59 | $1,475 | $1,038 | 70.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 13 | 15 | $2,625 | $1,024 | 39.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $1,405 | $997.78 | 71.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $920.00 | $824.08 | 89.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $572.00 | $109.90 | 19.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 11 | $165.00 | $104.72 | 63.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 74 | $740.00 | $59.88 | 8.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 11 | 11 | $220.00 | $31.41 | 14.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 71 | 71 | $28,400 | $8,991 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 102 | $16,968 | $8,914 | 52.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 66 | 67 | $17,018 | $8,353 | 49.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 71 | $7,930 | $4,278 | 54.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $3,846 | $2,385 | 62.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 17 | 36 | $4,932 | $2,294 | 46.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 15 | 16 | $4,064 | $1,896 | 46.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,560 | $1,680 | 47.2% |
About Dr. Nicholas Pantano, MD
Dr. Nicholas Pantano, MD is a Family Medicine healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2018. The National Provider Identifier (NPI) number assigned to this provider is 1417454463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Pantano, MD has received a total of $5,509 in payments from pharmaceutical and medical device companies, with $1,398 received in 2024. These payments were reported across 312 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,317).
As a Medicare-enrolled provider, Pantano has provided services to 1,057 Medicare beneficiaries, totaling 1,285 services with total Medicare billing of $99,119. Data is available for 3 years (2021–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williamsville, NY
- Active Since 04/06/2018
- Last Updated 04/18/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1417454463
Products in Payments
- TRELEGY ELLIPTA (Drug) $367.95
- JARDIANCE (Drug) $336.95
- TRULICITY (Drug) $233.92
- Ozempic (Drug) $214.73
- UBRELVY (Drug) $210.43
- INJECTAFER (Drug) $188.39
- Rybelsus (Drug) $187.03
- SHINGRIX (Biological) $181.47
- EMGALITY (Drug) $174.99
- Wegovy (Drug) $165.91
- VRAYLAR (Drug) $144.68
- ENROUTE Transcarotid Stent (Device) $135.27
- STIOLTO RESPIMAT (Drug) $129.43
- REXULTI (Drug) $123.63
- Veozah (Drug) $117.98
- Otezla (Drug) $115.66
- GARDASIL 9 (Biological) $104.22
- NURTEC ODT (Drug) $101.29
- Cologuard Collection Kit (Device) $101.00
- AirDuo Digihaler (Drug) $93.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsville
Jean Cange, M.d, M.D
Family Medicine — Payments: $28,012
Dr. Daniel Trock, M.d, M.D
Family Medicine — Payments: $22,227
Suchitra Koneru, M.d, M.D
Family Medicine — Payments: $15,123
Dr. David Pawlowski, Md, MD
Family Medicine — Payments: $14,600
Dr. Stacey Gugino, Md, MD
Family Medicine — Payments: $13,585
Dr. Karol Pohlman Rejman, Phd, Fnp, PHD, FNP
Family Medicine — Payments: $12,074